Association of beta-blockers beyond 1 year after myocardial infarction and cardiovascular outcomes

OBJECTIVE: Beta-blockers (BB) are an established treatment following myocardial infarction (MI). However, there is uncertainty as to whether BB beyond the first year of MI have a role in patients without heart failure or left ventricular systolic dysfunction (LVSD). METHODS: A nationwide cohort stud...

Descripción completa

Detalles Bibliográficos
Autores principales: Ishak, Divan, Aktaa, Suleman, Lindhagen, Lars, Alfredsson, Joakim, Dondo, Tatendashe Bernadette, Held, Claes, Jernberg, Tomas, Yndigegn, Troels, Gale, Chris P, Batra, Gorav
Formato: Online Artículo Texto
Lenguaje:English
Publicado: BMJ Publishing Group 2023
Materias:
Coronary Artery Disease
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10359586/
https://www.ncbi.nlm.nih.gov/pubmed/37130746
http://dx.doi.org/10.1136/heartjnl-2022-322115

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10359586/
https://www.ncbi.nlm.nih.gov/pubmed/37130746
http://dx.doi.org/10.1136/heartjnl-2022-322115

Ejemplares similares